Presbyopia is a widespread condition, with an estimated 1.8 billion people affected globally in 2015, a figure projected to reach approximately 2.1 billion by 2030, according to Australian researchers. Its prevalence is significant across various regions; for instance, 88.9% of individuals aged 45 and over in the United States and 76% in developing nations like Brazil experience presbyopia. Uncorrected presbyopia represents a major global health challenge, ranking among the leading causes of vision impairment, particularly prevalent in low- and middle-income countries. Left unaddressed, it leads to increasing difficulties with daily near-vision tasks and a decline in overall quality of life due to reduced visual clarity. Furthermore, presbyopia imposes substantial economic burdens. This includes high direct and indirect medical costs, alongside significant productivity losses. A 2011 study estimated the annual global productivity loss due to uncorrected and under-corrected presbyopia at 25.4 billion US dollars.